Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2023	Jan. 01, 2023
Operating activities:
Net income	$ 31,665	$ 48,838
Adjustments to reconcile net income to net cash provided by operating activities:
Intangible impairment	19,762	0
Depreciation and amortization	27,346	27,009
Amortization of deferred financing costs	361	671
Deferred income taxes	(6,108)	(846)
Bad debt expense	225	2,407
Stock-based compensation	4,595	3,454
Other non-cash items	(385)	(470)
Changes in operating items:
Trade receivables	(26,384)	(31,622)
Inventories	29,808	46,506
Prepaid and other	6,640	7,550
Accounts payable and accrued expenses	125,404	89,050
Other assets and liabilities	(169)	1,113
Net cash provided by operating activities	212,760	193,660
Investing activities:
Capital expenditures	(17,807)	(23,849)
Net cash used in investing activities	(17,807)	(23,849)
Financing activities:
Acquisition of treasury stock	(4,787)	(1,175)
Proceeds from exercise of employee stock options	44	0
Proceeds from bank borrowings	82,000	195,900
Repayment of bank borrowings	(87,000)	(205,900)
Debt issuance cost	0	(383)
Net cash used in financing activities	(9,743)	(11,558)
Net change in cash and cash equivalents	185,210	158,253
Cash and cash equivalents:
Beginning of period	126,807	31,465
End of period	$ 312,017	$ 189,718